Page last updated: 2024-08-21

triethylenephosphoramide and Carcinoma, Transitional Cell

triethylenephosphoramide has been researched along with Carcinoma, Transitional Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bibby, MC; Fenwick, E; Jenkins, WE; Loadman, PM; Masters, JR; McDermott, BJ; Mundy, AR; Shah, PJ1

Trials

1 trial(s) available for triethylenephosphoramide and Carcinoma, Transitional Cell

ArticleYear
ThioTEPA pharmacokinetics during intravesical chemotherapy and the influence of Tween 80.
    Cancer chemotherapy and pharmacology, 1990, Volume: 25, Issue:4

    Topics: Absorption; Administration, Intravesical; Aged; Carcinoma, Transitional Cell; Female; Humans; Hydrogen-Ion Concentration; Leukocyte Count; Male; Middle Aged; Osmolar Concentration; Polysorbates; Random Allocation; Thiotepa; Triethylenephosphoramide; Urinary Bladder Neoplasms

1990